πŸ‡ΊπŸ‡Έ FDA
Patent

US 8058244

Cyclic peptide antitumor agents

granted A61KA61K38/12A61P

Quick answer

US patent 8058244 (Cyclic peptide antitumor agents) held by Northwestern University expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/12, A61P, A61P35/00